nach oben

Erschienen in:

01.03.2013 | Neurology and Preclinical Neurological Studies - Original Article

Functional evaluation of central cholinergic circuits in patients with Parkinson’s disease and REM sleep behavior disorder: a TMS study

verfasst von: Raffaele Nardone, Jürgen Bergmann, Francesco Brigo, Monica Christova, Alexander Kunz, Martin Seidl, Frediano Tezzon, Eugen Trinka, Stefan Golaszewski

Erschienen in: Journal of Neural Transmission | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Central cholinergic dysfunction has been reported in patients with Parkinsonʼs disease (PD) and hallucinations by evaluating short latency afferent inhibition (SAI), a transcranial magnetic stimulation protocol which gives the possibility to test an inhibitory cholinergic circuit in the human brain. REM sleep behavior disorder (RBD) was also found to be associated with cognitive impairment in PD patients. The objective of the study was to assess the cholinergic function, as measured by SAI, in PD patients with RBD (PD-RBD) and PD patients without RBD (PD-nRBD). We applied the SAI technique in 10 PD-RBD patients, in 13 PD-nRBD patients and in 15 age-matched normal controls. All PD patients and control subjects also underwent a comprehensive battery of neuropsychological tests. Mean SAI was significantly reduced in PD-RBD patients when compared with PD-nRBD patients and controls. Neuropsychological examination showed mild cognitive impairment in 9 out of the 10 PD-RBD patients, and in 5 out of the 13 PD-nRBD. SAI values correlated positively with neuropsychological tests measuring episodic verbal memory, executive functions, visuoconstructional and visuoperceptual abilities. Similar to that previously reported in the idiopathic form of RBD, SAI abnormalities suggest a cholinergic dysfunction in PD patients who develop cognitive impairment, and present findings indicate that RBD is an important determinant of MCI in PD.

American Academy of Sleep Medixine, Task Forse Chair; Hauri PJ, Chairman (2005) The international classification of sleep disorders: diagnostic and coding manual, 2nd edn. American Academy of Sleep Medicine, Westchester

Arnulf I, Bonnet AM, Damier P, Bejjani BP, Seilhean D, Derenne JP, Agid Y (2000) Hallucinations, REM sleep, and Parkinsonʼs disease: a medical hypothesis. Neurology 55:281–288PubMedCrossRef

Aston-Jones G, Rajkowski J, Cohen J (1999) Role of locus coeruleus in attention and behavioral flexibility. Biol Psychiatry 46:1309–1320PubMedCrossRef

Babiloni C, Binetti G, Cassetta E, Dal Forno G, Del Percio C, Ferreri F, Ferri R, Frisoni G, Hirata K, Lanuzza B, Miniussi C, Moretti DV, Nobili F, Rodriguez G, Romani GL, Salinari S, Rossini PM (2006) Sources of cortical rhythms change as a function of cognitive impairment in pathological aging: a multicenter study. Clin Neurophysiol 117:252–268PubMedCrossRef

Beck AT, Steer RA, Brown GK (1996) The Beck depression inventory, 2nd edn. The Psychological Corporation, San Antonio

Berridge CW, Page ME, Valentino RJ, Foote SL (1993) Effects of locus coeruleus inactivation on electroencephalographic activity in neocortex and hippocampus. Neuroscience 55:381–393PubMedCrossRef

Boeve BF, Silber MH, Ferman TJ, Lucas JA, Parisi JE (2001) Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Mov Disord 16:622–630PubMedCrossRef

Bohnen NI, Kaufer DI, Hendrickson R, Ivanco LS, Lopresti BJ, Constantine GM, Mathis ChA, Davis JG, Moore RY, Dekosky ST (2006) Cognitive correlates of cortical cholinergic denervation in Parkinsonʼs disease and Parkinsonian dementia. J Neurol 253:242–247PubMedCrossRef

Braak H, Rüb U, Jansen Steur EN, Del Tredici K, de Vos RA (2005) Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology 64:1404–1410PubMedCrossRef

Comella CL, Nardine TM, Diederich NJ, Stebbins GT (1998) Sleep-related violence, injury, and REM sleep behavior disorder in Parkinsonʼs disease. Neurology 51:526–529PubMedCrossRef

Di Lazzaro V, Oliviero A, Profice P, Pennisi MA, Di Giovanni S, Zito G, Tonali P, Rothwell JC (2000) Muscarinic receptor blockade has differential effects on the excitability of intracortical circuits in the human motor cortex. Exp Brain Res 135:455–461PubMedCrossRef

Di Lazzaro V, Oliviero A, Tonali PA, Marra C, Daniele A, Profice P, Saturno E, Pilato F, Masullo C, Rothwell JC (2002) Noninvasive in vivo assessment of cholinergic cortical circuits in AD using transcranial magnetic stimulation. Neurology 59:392–397PubMedCrossRef

Di Lazzaro V, Oliviero A, Profice P, Pennisi MA, Pilato F, Zito G, Dileone M, Nicoletti R, Pasqualetti P, Tonali PA (2003) Ketamine increases human motor cortex excitability to transcranial magnetic stimulation. J Physiol 547:485–496PubMedCrossRef

Di Lazzaro V, Oliviero A, Pilato F, Saturno E, Dileone M, Bentivoglio AR, Tonali A (2004a) Normal or enhanced short-latency afferent inhibition in Parkinsonʼs disease? Brain 127:E8PubMedCrossRef

Di Lazzaro V, Oliviero A, Pilato F, Saturno E, Dileone M, Marra C, Daniele A, Ghirlanda S, Gainotti G, Tonali PA (2004b) Motor cortex excitability to transcranial magnetic stimulation in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 75:555–559PubMedCrossRef

Di Lazzaro V, Oliviero A, Pilato F, Saturno E, Dileone M, Marra C, Ghirlanda S, Ranieri F, Gainotti G, Tonali (2005a) Neurophysiological predictors of long term response to AChE inhibitors in AD patients. J Neurol Neurosurg Psychiatry 76:1064–1069

Di Lazzaro V, Oliviero A, Saturno E, Di leone M, Pilato F, Nardone R, Ranieri F, Musumeci G, Fiorilla T, Tonali P (2005b) Effects of lorazepam on short latency afferent inhibition and short latency intracortical inhibition in humans. J Physiol 564:661–668PubMedCrossRef

Di Lazzaro V, Pilato F, Dileone M, Tonali PA, Ziemann U (2005c) Dissociated effects of diazepam and lorazepam on short-latency afferent inhibition. J Physiol 569:315–323PubMedCrossRef

Di Lazzaro V, Pilato F, Dileone M, Saturno E, Oliviero A, Marra C, Daniele A, Ranieri F, Gainotti G, Tonali PA (2006) In vivo cholinergic circuit evaluation in frontotemporal and Alzheimer dementias. Neurology 66:1111–1113PubMedCrossRef

Di Lazzaro V, Pilato F, Dileone M, Saturno E, Profice P, Marra C, Daniele A, Ranieri F, Quaranta D, Gainotti G, Tonali PA (2007) Functional evaluation of cerebral cortex in dementia with Lewy bodies. Neuroimage 37(2):422–429PubMedCrossRef

Emre M (2003) Dementia associated with Parkinsonʼs disease. Lancet Neurol 2:229–237PubMedCrossRef

Fahn S, Elton RL, members of the UPDRS Development Committee. Unified Parkinson’s Disease Rating Scale (1987) In: Fahn S, Marsden CD, Calne DB, Liebermann A (eds) Recent developments in Parkinson’s disease. Macmillan Health Care Information, Florham Park, pp 153–163

Fantini ML, Gagnon JF, Petit D, Rompré S, Décary A, Carrier J, Montplaisir J (2003) Slowing of electroencephalogram in rapid eye movement sleep behavior disorder. Ann Neurol 53(6):774–780PubMedCrossRef

Ferini-Strambi L, Di Gioia MR, Castronovo V, Oldani A, Zucconi M, Cappa SF (2004) Neuropsychological assessment in idiopathic REM sleep behavior disorder (RBD): does the idiopathic form of RBD really exist? Neurology 62(1):41–45PubMedCrossRef

Foltynie T, Brayne CE, Robbins TW, Barker RA (2004) The cognitive ability of an incident cohort of Parkinsonʼs patients in the UK. The CamPaIGN study. Brain 127:550–560PubMedCrossRef

Fujiki M, Hikawa T, Abe T, Ishii K, Kobayashi H (2006) Reduced short latency afferent inhibition in diffuse axonal injury patients with memory impairment. Neurosci Lett 405:226–230PubMedCrossRef

Gagnon JF, Bedard MA, Fantini ML, Petit D, Panisset M, Rompré S, Carrier J, Montplaisir J (2002a) REM sleep behavior disorder and REM sleep without atonia in Parkinsonʼs disease. Neurology 59:585–589PubMedCrossRef

Gagnon JF, Montplaisir J, Bédard MA (2002b) Les troubles du sommeil paradoxal dans la maladie de Parkinson. Rev Neurol 158:135–152PubMed

Gagnon JF, Fantini ML, Bedard MA, Petit D, Carrier J, Rompré S, Décary A, Panisset M, Montplaisir J (2004) Association between waking EEG slowing and REM sleep behavior disorder in PD without dementia. Neurology 62:401–406PubMedCrossRef

Glenville M, Wilkinson RT (1979) Portable devices for measuring performance in the field: the effects of sleep deprivation and might shift on the performance of computer operators. Ergonomics 22:927–933PubMedCrossRef

Green J, McDonald WM, Vitek JL, Evatt M, Freeman A, Haber M, Bakay RA, Triche S, Sirockman B, DeLong MR (2002) Cognitive impairments in advanced PD without dementia. Neurology 59:1320–1324PubMedCrossRef

Helkala EL, Laulumaa V, Soininen H, Riekkinen PJ (1988) Recall and recognition memory in patients with Alzheimerʼs and Parkinsonʼs diseases. Ann Neurol 24:214–217PubMedCrossRef

Hendricks JC, Morrison AR, Mann GL (1982) Different behaviors during paradoxical sleep without atonia depend on pontine lesion site. Brain Res 239:81–105PubMedCrossRef

Hilker R, Thomas AV, Klein JC, Weisenbach S, Kalbe E, Burghaus L, Jacobs AH, Herholz K, Heiss WD (2005) Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways. Neurology 65:1716–1722PubMedCrossRef

Inglis WL, Olmstead MC, Robbins TW (2001) Selective deficits in attentional performance on the 5-choice serial reaction time task following pedunculopontine tegmental nucleus lesions. Behav Brain Res 123:117–131PubMedCrossRef

Iranzo A, Molinuevo JL, Santamaria J, Serradell M, Martí MJ, Valldeoriola F, Tolosa E (2006) Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol 5:572–577PubMedCrossRef

Janvin C, Aarsland D, Larsen JP, Hugdahl K (2003) Neuropsychological profile of patients with Parkinsonʼs disease without dementia. Dement Geriatr Cogn Disord 15:126–131PubMedCrossRef

Janvin CC, Larsen JP, Aarsland D, Hugdahl K (2006) Subtypes of mild cognitive impairment in Parkinson’s disease. Mov Disord 21(9):1343–1349PubMedCrossRef

Jones BE (2000) Basic mechanisms of sleep–wake states. In: Kryger MH, Roth T, Dement WC (eds) Principles and practice of sleep medicine, 3rd edn. Saunders, Philadelphia, pp 134–154

Jouvet M, Delorme F (1965) Locus coeruleus et sommeil paradoxal. C R Soc Biol 159:895–899

Kleiner S, Bringmann A (1996) Nucleus basalis magnocellularis and pedunculopontine tegmental nucleus: control of the slow EEG waves in rats. Arch Ital Biol 134:153–167PubMed

Kimura J, Daube J, Burke D, Hallett M, Cruccu G, Ongerboer de Visser BW, Yanagisawa N, Shimamura M, Rothwell J (1994) Human reflexes and late responses. Report of an IFCN committee. Electroencephalogr Clin Neurophysiol 40:393–403

Kujirai T, Caramia MD, Rothwell JC, Day BL, Thompson PD, Ferbert A, Wroe S, Asselman P, Marsden CD (1993) Corticocortical inhibition in human motor cortex. J Physiol 471:501–519PubMed

Levin BE, Llabre MM, Reisman S, Weiner WJ, Sanchez-Ramos J, Singer C, Brown MC (1991) Visuospatial impairment in Parkinsonʼs disease. Neurology 41:365–369PubMedCrossRef

Lezak MD, Howieson DB, Loring DW (2004) Neuropsychological assessment, 4th edn. Oxford University Press, New York

Mahowald MW, Schenck CH (2000) REM sleep parasomnias. In: Kryger MH, Roth T, Dement WC (eds) Principles and practice of sleep medicine, 3rd edn. Saunders, Philadelphia, pp 724–741

Manganelli F, Vitale C, Santangelo G, Pisciotta C, Iodice R, Cozzolino A, Dubbioso R, Picillo M, Barone P, Santoro L (2009) Functional involvement of central cholinergic circuits and visual hallucinations in Parkinsonʼs disease. Brain 132(Pt 9):2350–2355PubMedCrossRef

Martorana A, Mori F, Esposito Z, Kusayanagi H, Monteleone F, Codecà C, Sancesario G, Bernardi G, Koch G (2009) Dopamine modulates cholinergic cortical excitability in Alzheimerʼs disease patients. Neuropsychopharmacology 34(10):1328–2323

Massicotte-Marquez J, Décary A, Gagnon JF, Vendette M, Mathieu A, Postuma RB, Carrier J, Montplaisir J (2008) Executive dysfunction and memory impairment in idiopathic REM sleep behavior disorder. Neurology 70(15):1250–1257PubMedCrossRef

Muslimovic D, Post B, Speelman JD, Schmand B (2005) Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 65:1239–1245PubMedCrossRef

Nardone R, Florio I, Lochner P, Tezzon F (2005) Cholinergic cortical circuits in Parkinsonʼs disease and in progressive supranuclear palsy: a transcranial magnetic stimulation study. Exp Brain Res 163:128–131PubMedCrossRef

Nardone R, Bergmann J, Christova M, Caleri F, Tezzon F, Ladurner G, Trinka E, Golaszewski S (2012a) Short latency afferent inhibition differs among the subtypes of mild cognitive impairment. J Neural Transm 119(4):463–471PubMedCrossRef

Nardone R, Bergmann J, Kunz A, Christova M, Brigo F, Tezzon F, Trinka E, Golaszewski S (2012b) Cortical afferent inhibition is reduced in patients with idiopathic REM sleep behavior disorder and cognitive impairment. Sleep Med 13(7):919–925PubMedCrossRef

Perry E, Walker M, Grace J, Perry R (1999) Acetylcholine in mind: a neurotransmitter correlate of consciousness? Trends Neurosci 22:273–280PubMedCrossRef

Postuma RB, Gagnon JF, Vendette M, Montplaisir JY (2009) Idiopathic REM sleep behavior disorder in the transition to denerative disease. Mov Disord 24(15):2225–2232PubMedCrossRef

Postuma RB, Bertrand JA, Montplaisir J, Desjardins C, Vendette M, Rios Romenets S, Panisset M, Gagnon JF (2012) Rapid eye movement sleep behavior disorder and risk of dementia in Parkinsonʼs diesease: a prospective study. Mov Disord 27(6):720–726PubMedCrossRef

Petersen RC, Morris JC (2005) Mild cognitive impairment as a clinical entity and treatment target. Arch Neurol 62(7):1160–1163PubMedCrossRef

Prichep LS, John ER, Ferris SH, Reisberg B, Almas M, Alper K, Cancro R (1994) Quantitative EEG correlates of cognitive deterioration in the elderly. Neurobiol Aging 15:85–90PubMedCrossRef

Rossini PM, Barker T, Berardelli A, Caramia MD, Caruso G, Cracco RQ, Dimitrijevic MR, Hallett M, Katayama Y, Lucking CH, Maertens de Noordhout AL, Marsden CD, Murray NMF, Rothwell JC, Swash M, Tomberg C (1994) Non invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application: report of IFCN committee. Electroenceph Clin Neurophysiol 91:79–92PubMedCrossRef

Rowe JB, Hughes L, Ghosh BC, Eckstein D, Williams-Gray CH, Fallon S, Barker RA, Owen AM (2008) Parkinson’s disease and dopaminergic therapy—differential effects on movement, reward and cognition. Brain 131(Pt 8):2094–2105PubMedCrossRef

Sailer A, Molnar GF, Paradiso G, Gunraj CA, Lang AE, Chen R (2003) Short and long latency afferent inhibition in Parkinson’s disease. Brain 26:1883–1894CrossRef

Schenck CH, Bundlie SR, Mahowald MW (1996a) Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder. Neurology 46:388–393PubMedCrossRef

Schenck CH, Garcia-Rill E, Skinner RD, Anderson ML, Mahowald MW (1996b) A case of REM sleep behavior disorder with autopsy-confirmed Alzheimerʼs disease: post-mortem brain stem histochemical analyses. Biol Psychiatry 40:422–425PubMedCrossRef

Steckler T, Inglis W, Winn P, Sahgal A (1994) The pedunculopontine tegmental nucleus: a role in cognitive processes? Brain Res Rev 19:298–318PubMedCrossRef

Terzaghi M, Sinforiani E, Zucchella C, Zambrelli E, Pasotti C, Rustioni V, Manni R (2008) Cognitive performance in REM sleep behaviour disorder: a possible early marker of neurodegenerative disease? Sleep Med 9(4):343–351PubMedCrossRef

Tokimura H, Di Lazzaro V, Tokimura Y, Oliviero A, Profice P, Insola A, Mazzone P, Tonali P, Rothwell JC (2000) Short latency inhibition of human hand motor cortex by somatosensory input from the hand. J Physiol 523:503–513PubMedCrossRef

Turner RS, D’Amato CJ, Chervin RD, Blaivas M (2000) The pathology of REM sleep behavior disorder with comorbid Lewy body dementia. Neurology 55:1730–1732PubMedCrossRef

Uchiyama M, Isse K, Tanaka K, Yokota N, Hamamoto M, Aida S, Ito Y, Yoshimura M, Okawa M (1995) Incidental Lewy body disease in a patient with REM sleep behavior disorder. Neurology 45:709–712PubMedCrossRef

Vendette M, Gagnon JF, Décary A, Massicotte-Marquez J, Postuma RB, Doyon J, Panisset M, Montplaisir J (2007) REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia. Neurology 69(19):1843–1849PubMedCrossRef

Wilkinson RT, Houghton D (1975) Portable four-choise reaction timewith magnetic tape memory. Behav Res Methods Instum 7:441–446CrossRef

Williams-Gray CH, Hampshire A, Robbins TW, Owen AM, Barker RA (2007) Catechol O-methyltransferease Vall58Met genotyper influences frontoparietal activity during planning in patients with Parkinson’s disease. J Neurosci 27(18):4832–4838PubMedCrossRef

Winn P (1998) Frontal syndrome as a consequence of lesions in the pedunculopontine tegmental nucleus: a short theoretical review. Brain Res Bull 47:551–563PubMedCrossRef

Ziemann U, Lonnecker S, Steinhoff BH, Paulus W (1996) Effects of antiepileptics drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study. Ann Neurol 40:367–378PubMedCrossRef

Ziemann U, Paulus W, Nitsche MA, Pascual-Leone A, Byblow WD, Berardelli A, Siebner HR, Classen J, Cohen LG, Rothwell JC (2008) Consensus: motor cortex plasticity protocols. Brain Stimul 1:164–182PubMedCrossRef

Titel: Functional evaluation of central cholinergic circuits in patients with Parkinson’s disease and REM sleep behavior disorder: a TMS study
verfasst von: Raffaele Nardone
Jürgen Bergmann
Francesco Brigo
Monica Christova
Alexander Kunz
Martin Seidl
Frediano Tezzon
Eugen Trinka
Stefan Golaszewski
Publikationsdatum: 01.03.2013
Verlag: Springer Vienna
Erschienen in: Journal of Neural Transmission / Ausgabe 3/2013
Print ISSN: 0300-9564
Elektronische ISSN: 1435-1463
DOI: https://doi.org/10.1007/s00702-012-0888-6

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Demenz Nachrichten

Der Einsatz von Antipsychotika gegen psychische und Verhaltenssymptome in Zusammenhang mit Demenzerkrankungen erfordert eine sorgfältige Nutzen-Risiken-Abwägung. Neuen Erkenntnissen zufolge sind auf der Risikoseite weitere schwerwiegende Ereignisse zu berücksichtigen.

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2013

Rating scales for cervical dystonia: a critical evaluation of tools for outcome assessment of botulinum toxin therapy

Region-specific causal mechanism in the effects of ammonia on cerebral glucose metabolism in the rat brain

Efficacy and safety of higher doses of botulinum toxin type A NT 201 free from complexing proteins in the upper and lower limb spasticity after stroke

What is measured with verbal fluency tests in Parkinson’s disease patients at different stages of the disease?

Levodopa changes brain motor network function during ankle movements in Parkinson’s disease